References analysis of the Wikipedia article "Cytokine-induced killer cell" in the English version

doi.org

Schmidt-Wolf, IG; Negrin, RS; Kiem, HP; Blume, KG; Weissman, IL (1 July 1991). "Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity". The Journal of Experimental Medicine. 174 (1): 139–49. doi:10.1084/jem.174.1.139. PMC 2118875. PMID 1711560.

Lu, PH; Negrin, RS (15 August 1994). "A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency". Journal of Immunology. 153 (4): 1687–96. doi:10.4049/jimmunol.153.4.1687. PMID 7519209. S2CID 23803853.

Pievani, A; Borleri, G; Pende, D; Moretta, L; Rambaldi, A; Golay, J; Introna, M (22 September 2011). "Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity". Blood. 118 (12): 3301–10. doi:10.1182/blood-2011-02-336321. PMID 21821703.

Godfrey, DI; MacDonald, HR; Kronenberg, M; Smyth, MJ; Van Kaer, L (March 2004). "NKT cells: what's in a name?". Nature Reviews. Immunology. 4 (3): 231–7. doi:10.1038/nri1309. PMID 15039760. S2CID 19442375.

Introna, M; Pievani, A; Borleri, G; Capelli, C; Algarotti, A; Micò, C; Grassi, A; Oldani, E; Golay, J; Rambaldi, A (November 2010). "Feasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantation". Biology of Blood and Marrow Transplantation. 16 (11): 1603–7. doi:10.1016/j.bbmt.2010.05.015. PMID 20685246.

Rosato Antonio, Cappuzzello Elisa (30 June 2016). "Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies". Oncoimmunology. 5 (8): e1199311. doi:10.1080/2162402X.2016.1199311. PMC 5007963. PMID 27622068.

Rosato Antonio, Sommaggio Roberta (Aug 2017). "Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells". Cytokine Growth Factor Rev. 36: 99–105. doi:10.1016/j.cytogfr.2017.06.003. hdl:11577/3243034. PMID 28629761.

Li, H; Yu, JP; Cao, S; Wei, F; Zhang, P; An, XM; Huang, ZT; Ren, XB (May 2007). "CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients". Journal of Clinical Immunology. 27 (3): 317–26. doi:10.1007/s10875-007-9076-0. PMID 17468835. S2CID 21924179.

Schmeel, LC; Schmeel, FC; Coch, C; Schmidt-Wolf, IG (8 November 2014). "Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)". Journal of Cancer Research and Clinical Oncology. 141 (5): 839–49. doi:10.1007/s00432-014-1864-3. PMID 25381063. S2CID 11940173.

Hontscha, C; Borck, Y; Zhou, H; Messmer, D; Schmidt-Wolf, IG (February 2011). "Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)". Journal of Cancer Research and Clinical Oncology. 137 (2): 305–10. doi:10.1007/s00432-010-0887-7. PMID 20407789. S2CID 12018626.

Jäkel, Clara E; Schmidt-Wolf, Ingo GH (July 2014). "An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells". Expert Opinion on Biological Therapy. 14 (7): 905–916. doi:10.1517/14712598.2014.900537. PMID 24673175. S2CID 21285433.

Schmidt-Wolf, IG; Finke, S; Trojaneck, B; Denkena, A; Lefterova, P; Schwella, N; Heuft, HG; Prange, G; Korte, M; Takeya, M; Dorbic, T; Neubauer, A; Wittig, B; Huhn, D (November 1999). "Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma". British Journal of Cancer. 81 (6): 1009–16. doi:10.1038/sj.bjc.6690800. PMC 2362953. PMID 10576658.

Märten, A; Ziske, C; Schöttker, B; Renoth, S; Weineck, S; Buttgereit, P; Schakowski, F; von Rücker, A; Sauerbruch, T; Schmidt-Wolf, IG (2000). "Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations". Journal of Immunotherapy. 24 (6): 502–10. doi:10.1097/00002371-200111000-00007. PMID 11759073. S2CID 41096583.

Schmidt, J; Eisold, S; Büchler, MW; Märten, A (November 2004). "Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma". Cancer Immunology, Immunotherapy. 53 (11): 1018–26. doi:10.1007/s00262-004-0554-4. PMC 11032841. PMID 15185013. S2CID 24874819.

Hombach, AA; Rappl, G; Abken, H (December 2013). "Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation"". Molecular Therapy. 21 (12): 2268–77. doi:10.1038/mt.2013.192. PMC 3863798. PMID 23985696.

Tettamanti, Sarah; Marin, Virna; Pizzitola, Irene; Magnani, Chiara F.; Giordano Attianese, Greta M. P.; Cribioli, Elisabetta; Maltese, Francesca; Galimberti, Stefania; Lopez, Angel F.; Biondi, Andrea; Bonnet, Dominique; Biagi, Ettore (May 2013). "Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor". British Journal of Haematology. 161 (3): 389–401. doi:10.1111/bjh.12282. PMID 23432359. S2CID 20084806.

Chan, JK; Hamilton, CA; Cheung, MK; Karimi, M; Baker, J; Gall, JM; Schulz, S; Thorne, SH; Teng, NN; Contag, CH; Lum, LG; Negrin, RS (15 March 2006). "Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study". Clinical Cancer Research. 12 (6): 1859–67. doi:10.1158/1078-0432.ccr-05-2019. PMID 16551871.

Tita-Nwa, F; Moldenhauer, G; Herbst, M; Kleist, C; Ho, AD; Kornacker, M (December 2007). "Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells". Cancer Immunology, Immunotherapy. 56 (12): 1911–20. doi:10.1007/s00262-007-0333-0. PMC 11029829. PMID 17487487. S2CID 2599140.

nih.gov

pubmed.ncbi.nlm.nih.gov

Schmidt-Wolf, IG; Lefterova, P; Mehta, BA; Fernandez, LP; Huhn, D; Blume, KG; Weissman, IL; Negrin, RS (December 1993). "Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells". Experimental Hematology. 21 (13): 1673–9. PMID 7694868.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Cytokine-induced killer cell (English Wikipedia)